3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Multiple Myeloma
3
Mucositis
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Febrile Neutropenia
2
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Lymphoma, Non-Hodgkin
1
Inflammation
1
Hematologic Neoplasms
1
Early Stage Triple Negative ER Low Breast Cancer
1
Disease Progression
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Arthritis, Rheumatoid
1
Interventions
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Early Stage Triple Negative ER Low Breast Cancer
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT06710197
2026-03-05
OZM-034
University Health Network, Toronto
Phase 2
Withdrawn